Skip to main content

Advertisement

Table 1 Demographic and clinical characteristics of patients with juvenile idiopathic arthritis (N = 51) and controls (N = 52).

From: Homocysteine and lipid profile in children with Juvenile Idiopathic Arthritis

  Patients Controls
Epidemiological Characteristics n (%) n (%)
Gender     
   Female 37 (72.6) 42 (80.1)
   Male 14 (27.4) 10 (19.9)
Origin     
   Caucasian 38 (74.5) 27 (51.9)
   Non Caucasian 13 (25,5) 25 (48.1)
Age at disease onset (years)     
   Range 1–12 -
   Mean ± SD 5.6 ± 3.2 -
   Median 5.8 -
Current age (years)     
   Medium ± DP 11.3 ± 4.2 12.5 ± 3.5
   Median 12.3 13
Onset type JIA     
   Oligoarticular 22 (43.1%) -
   Polyarticular 17 (33.3%) -
   Systemic 12 (23.6%) -
Course type     
   Oligoarticular 29 (56.9%) -
   Polyarticular 22 (43.1%) -
Active disease treatment 27 (52.9%)   
   Methotrexate 32 (62.7%)   
   NSAIDs 26 (51%)   
   Chloroquine 10 (13.9%)   
   Folic acid 32 (62.7%)   
   Systemic steroids 4 (7.8%)   
  1. JIA: juvenile idiopathic arthritis, NSAID s: nonsteroidal anti-inflammatory drugs